clopidogrel bisulfate tablets

indications

secondary prevention of atherosclerosis events in following patients:

patients with non-st-segment elevation acute coronary syndrome (unstable angina and non-st-elevation myocardial infarction), including patients undergoing a stent placement after percutaneous coronary intervention (pci). should be administered in conjunction with aspirin.

patients with acute st-elevation myocardial infarction. should be administered in conjunction with aspirin during thrombolytic therapy.

patients suffering from myocardial infarction (from a few days to less than 35 days), ischemic stroke (from 7 days to less than 6 months) or established peripheral arterial disease.

declaration:

the detailed prescription information of this product should be subject to confirmation by the latest approved version of the state food and drug administration.

the product information on this website is not for pharmaceutical advertising, but presented as product knowledge for the reference of professionals in the pharmaceutical industry only. it must not be used for the diagnosis of diseases, and it cannot replace medical advice provided by doctors or other qualified medical professionals.